KMT2A and acute lymphoblastic leukemia: In B-ALL patients, 25–30% of patients have hyperdiploidy, 25% have t(12;21), 3–5% have t(9;22), 10% have MLL translocations, and 2% have iAMP21 chromosomal abnormalities.